Immuto Scientific

Immuto is a biotechnology company that is transforming the way biotherapeutics are discovered. Protein structural analysis is an essential step in the drug discovery process, and compared to all other methods used today, our suite of proprietary technologies enables assessment of drug binding, target conformation, and interactions with an unprecedented degree of accuracy and speed. With our industry leading structure-based platform, we enable the discovery of next generation therapeutics against the most challenging targets. Using our patented approach, we are on a mission to demystify and democratize protein structure, function, and dynamics - driving rationally designed drug development at unprecedented...

Biologics,structural biology,rational design,drug design,antibody engineering,antibody discovery,antibody drug conjugates,structural proteomics,proteomics,affinity maturation,lead optimization,hematology,solid tumors,oncology,and mabs

Immuto scientific operates in the Biotechnology research industry.

Immuto scientific's revenue is 11m - 100m

Immuto scientific has 11 - 50 employees.